Superior Group Reports Mixed Q2 2026: Revenue Up but Net Income Dips
Event summary
- Q2 2026 net sales rose to $147.8M, up from $144.0M in the prior year.
- Net income fell to $1.2M (including a $2M non-cash tradename impairment charge) from $1.6M in Q2 2025.
- Adjusted EBITDA increased to $7.7M, up from $6.1M in the prior year quarter.
- Board approved a $0.14 per share quarterly dividend, payable August 28, 2026.
- Full-year outlook confirmed: net sales projected between $572M and $585M.
The big picture
Superior Group's Q2 2026 results highlight a mixed performance with revenue growth offset by a non-cash impairment charge in Healthcare Apparel. The company's diversified business model, including strong Branded Products performance, positions it to navigate soft market conditions. Strategic acquisitions and a healthy balance sheet remain key drivers for continued growth and shareholder value.
What we're watching
- Segment Performance
- How the Branded Products segment's strong performance will offset Healthcare Apparel's impairment challenges.
- Market Conditions
- Whether Superior Group can sustain growth amid soft market conditions and global economic uncertainties.
- Execution Risk
- The pace at which the company can integrate acquisitions and manage its expanding operations effectively.
Related topics
